Navigation Links
Codexis Names Vonnie Estes to New Technology Strategic Planning VP Role
Date:3/10/2010

REDWOOD CITY, Calif., March 10 /PRNewswire/ -- Codexis, Inc. today announced that Vonnie Estes has joined the company as Vice President, Strategic Planning, Technology.  In this new position, Ms. Estes will be responsible for moving Codexis' technical developments to commercial applications.  She will report to David Anton, Ph.D., Senior Vice President, Research and Development.

Ms. Estes brings Codexis two decades of experience leading product and commercial development programs for global chemical companies, most recently focusing on biofuels. She joins Codexis from DuPont Danisco Cellulosic Ethanol, where she was Vice President, Commercial Development. Previously, she was New Venture Manager, Cellulosic Biofuels for DuPont Advanced Biofuels, where she helped create the commercialization strategy for the DuPont cellulosic ethanol technology.  She also held business development management positions at various companies including Monsanto and Syngenta.  Ms. Estes holds a Bachelor of Science degree from the University of New Mexico and a Master of Science degree in plant pathology from the University of California, Davis.

"Vonnie Estes is a talented and experienced professional with a proven track record in successful development and commercialization of new technology," Dr. Anton said.  "She combines experience from major global corporations and entrepreneurial startups, and will play an important role in commercialization of our technical portfolio and strategy.  We are delighted to welcome her to Codexis."

Codexis, Inc. is a leading provider of optimized biocatalysts that make existing industrial processes faster, cleaner and more efficient than current methods and have the potential to make new industrial processes possible at commercial scale.  Codexis has commercialized its biocatalysts in the pharmaceutical industry and is developing biocatalysts for use in producing advanced biofuels under a multi-year research and development collaboration. The company is also using its technology platform to pursue biocatalyst-enabled solutions in other bioindustrial markets, including carbon management, water treatment and chemicals. 

Contact: Lyn Christenson, lyn.christenson@codexis.com, 650-421-8144 or Saskia Sidenfaden, ssidenfaden@mww.com, 212-827-3771.

SOURCE Codexis, Inc.

Back to top

RELATED LINKS
http://www.codexis.com

'/>"/>

SOURCE Codexis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Codexis Appoints Singapore Laboratories Managing Director
2. Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology
3. Bruce Pasternack Elected to Codexis Board
4. Codexis Opens Singapore Laboratory
5. Rothwell, Wolf Elected to Codexis Board
6. Codexis Launches Codex(TM) MicroCyp Platform to Produce Drug Metabolites and Novel Lead Compounds
7. Codexis Names David Anton VP Bioindustrials R&D
8. Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering
9. Codexis, Arch Announce Expanded Collaboration
10. Codexis Names Vice President, Intellectual Property
11. Codexis, Teva in Licensing Agreement Final
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/21/2017)...   Boston Biomedical , an industry leader in ... stemness pathways, today presented data from two clinical studies ... American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium ... In a Phase Ib/II study of napabucasin – ... stemness pathways by targeting STAT3 – colorectal cancer (CRC) ...
(Date:1/20/2017)... 20, 2017 Stock-Callers.com explores the ... influenced the most recent performances of select equities. In ... RGLS ), Abeona Therapeutics Inc. (NASDAQ: ... ), and Sage Therapeutics Inc. (NASDAQ: SAGE ... View Research, global Biotech market size is expected to reach $604.40 billion by ...
(Date:1/20/2017)... NEW YORK , January 20, 2017 ... Health Organization, cancer is one of leading causes of ... in 2012. Although the number of cancer related deaths ... since 1990. Rising in incidence rate of various cancers ... According to a research report by Global Market Insights, ...
(Date:1/19/2017)... , Jan 19, 2017 Research and ... by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity Analysis ... ... forecasts that the global market is projected to reach $15,737 million ... 13% from 2016 to 2022. Omic technologies segment ...
Breaking Biology Technology:
(Date:12/20/2016)... and GENEVA, Dec, 20, 2016   Valencell ... sensor technology, and STMicroelectronics (NYSE: STM), a ... of electronics applications, announced today the launch of ... for biometric wearables that includes ST,s compact ... Valencell,s Benchmark™ biometric sensor system. Together, SensorTile ...
(Date:12/16/2016)... -- The global wearable medical device market, in terms of value, ... 5.31 billion in 2016, at a CAGR of 18.0% during the ... ... medical devices, launch of a growing number of smartphone-based healthcare apps ... providers, and increasing focus on physical fitness. Furthermore, ...
(Date:12/15/2016)... Advancements in biometrics will radically ... wellbeing (HWW), and security of vehicles by ... vehicles begin to feature fingerprint recognition, iris ... monitoring, brain wave monitoring, stress detection, fatigue ... detection. These will be driven by built-in, ...
Breaking Biology News(10 mins):